Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.
Also called NCT07571447
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Phase 4
- Enrolled
- 220 participants
- Registry
-
NCT07571447
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07571447. Randomized; no masking; primary purpose health services research. Start 2026-09 (anticipated); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation
- Acronym
- CARDIOZOLAM-1
- Condition
- Atrial Fibrillation (AF)
- Condition
- Atrial Flutter
- Intervention (Other)
- One-step cardiologist-only midazolam sedation
- Intervention (Other)
- Two-step anaesthesiologist-assisted propofol sedation
- Lead sponsor
- Gødstrup Hospital
- Collaborator
- University of Aarhus
Record details
- Record id
cardio:ct-nct07571447- Content hash
8f9ba4e0eee88cf64ba90740902ce7952683aa9040f48941187ddb14b54d3c72